Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia

Blood. 2014 Mar 27;123(13):2066-74. doi: 10.1182/blood-2012-12-469833. Epub 2014 Feb 3.

Abstract

Distinct patterns of DNA methylation characterize the epigenetic landscape of promyelocytic leukemia/retinoic acid receptor-α (PML-RARα)-associated acute promyelocytic leukemia (APL). We previously reported that the microRNAs (miRNAs) clustered on chromosome 14q32 are overexpressed only in APL. Here, using high-throughput bisulfite sequencing, we identified an APL-associated hypermethylation at the upstream differentially methylated region (DMR), which also included the site motifs for the enhancer blocking protein CCCTC-binding factor (CTCF). Comparing the profiles of diagnostic/remission paired patient samples, we show that hypermethylation was acquired in APL in a monoallelic manner. The cytosine guanine dinucleotide status of the DMR correlated with expression of the miRNAs following a characteristic position-dependent pattern. Moreover, a signature of hypermethylation was also detected in leukemic cells from an established transgenic PML-RARA APL mouse model at the orthologous region on chromosome 12, including the CTCF binding site located upstream from the mouse miRNA cluster. These results, together with the demonstration that the region does not show DNA methylation changes during myeloid differentiation, provide evidence that 14q32 hypermethylation is implicated in the pathogenesis of APL. We propose a model in which loss of imprinting at the 14q32 domain leads to overexpression of the miRNAs in APL.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Chromosomes, Human, Pair 14 / genetics*
  • DNA Methylation
  • Gene Expression Regulation, Leukemic
  • Genomic Imprinting*
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Leukemia, Promyelocytic, Acute / genetics*
  • Mice
  • MicroRNAs / genetics*
  • Microarray Analysis
  • Transcriptome

Substances

  • MicroRNAs